Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2022-06-07
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 28
- Registration Number
- NCT05408104
- Locations
- πΊπΈ
University of Chicago Medical Center, Chicago, Illinois, United States
Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-06-01
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 10
- Registration Number
- NCT05399498
- Locations
- πΊπΈ
University of Chicago, Chicago, Illinois, United States
Reintegration of Children From Institutions in Azerbaijan
Not Applicable
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-05-31
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 400
- Registration Number
- NCT05396625
- Locations
- π¦πΏ
National Mental Health Centre under the Ministry of Health, Republic of Azerbaijan, Baku, Azerbaijan
π¦πΏResearch and Education Center, Baku, Azerbaijan
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-05-18
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 43
- Registration Number
- NCT05379959
- Locations
- πΊπΈ
University of Chicago, Chicago, Illinois, United States
Antidepressant Effects of Nitrous Oxide
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 172
- Registration Number
- NCT05357040
- Locations
- πΊπΈ
University of Chicago Medicine, Chicago, Illinois, United States
π¦πΊThe Alfred Hospital, Melbourne, Victoria, Australia
Nitrous Oxide as Treatment for Fibromyalgia
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 50
- Registration Number
- NCT05357066
- Locations
- πΊπΈ
University of Chicago, Chicago, Illinois, United States
GI Oxalate Absorption
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 30
- Registration Number
- NCT05356000
- Locations
- πΊπΈ
University of Chicago Medical Center, Chicago, Illinois, United States
Caplyta in Borderline Personality Disorder
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 60
- Registration Number
- NCT05356013
- Locations
- πΊπΈ
University of Chicago Medical Center, Chicago, Illinois, United States
Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery
- First Posted Date
- 2022-04-28
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 90
- Registration Number
- NCT05351229
- Locations
- πΊπΈ
University of Chicago, Chicago, Illinois, United States
The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2022-04-26
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 1
- Registration Number
- NCT05346653
- Locations
- πΊπΈ
University of Chicago, Chicago, Illinois, United States
Β© Copyright 2024. All Rights Reserved by MedPath